期刊
CLINICAL RHEUMATOLOGY
卷 28, 期 11, 页码 1349-1350出版社
SPRINGER LONDON LTD
DOI: 10.1007/s10067-009-1259-z
关键词
Adalimumab; Anti-TNF; Lymphoedema; Psoriatic arthritis
类别
Lymphoedema is a rare complication of psoriatic arthritis (PsA) and inflammatory joint disease, with no response noted to disease-modifying drugs. However, reports are emerging of a beneficial effect on lymphoedema in patients treated with tumor necrosis factor-alpha antagonists for PsA (Etanercept), rheumatoid arthritis (Etanercept) and ankylosing spondylitis (Infliximab). We describe a psoriatic arthritis patient whose lymphoedema greatly improved following commencement of adalimumab.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据